Market Cap 9.00B
Revenue (ttm) 739.02M
Net Income (ttm) -436.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -59.05%
Debt to Equity Ratio -3.65
Volume 1,075,325
Avg Vol 2,300,924
Day's Range N/A - N/A
Shares Out 124.71M
Stochastic %K 95%
Beta 1.53
Analysts Strong Sell
Price Target $71.76

Company Profile

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-pow...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 855 698 8887
Fax: 888 974 4258
Address:
3100 Hanover Street, Palo Alto, United States
Gator5326
Gator5326 Oct. 27 at 12:38 PM
$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZ-2FtX741n0Z6WOyiD4GHhsE2ot5GqmAvyBExw8uY-2BwbjPTzHaP7bKqEpZmadhOl9zFfYwOJqXOBKDlZD7Us-2FeyD8y7z46F6g99dFNH4muQpwFgwwtdTph5FXl5yTVXWQt-2FbmKCa8Nz1euwQSRZXVcJfSkRa1KYNzsQHWFJ-2BQsOvbtuYDGmLgm1Pjpzyk8EgvLxw-3D-3DhSVn_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMvl-2BOrlyeCDUu2kwjGbk6bRymO58QHLh7xFAgbOsDXU1yE4V4onqmynjgpQUylrrmnPQluM9zGrh4qFeKmppq0aZ1tObjyWcNVrnGpM4Ucsj8AseoZnYwl43NHabvyGSeu06KYZJhMbMku0be4k8Snx8c-2FUQKczO7CpNahJyE7zQ11BrArQpeGDvn0Jybsr4tpBziHR1MSCuV09pC1FCNQCvrgT3W4CDSx-2FlziTK12SOqZHtEcNGrtgWaPwHaZXBxtXWsxfjGQ4gZ-2BbqxbufTxiQrTAuy0k1MA6PtsNjYmK3 😎😎😎
0 · Reply
Gator5326
Gator5326 Oct. 27 at 11:15 AM
$GH 90% adherence means one thing…..increased revenues! 😎
0 · Reply
G101SPM
G101SPM Oct. 27 at 9:55 AM
$GH $72.15 last bid. Holding long position at $15.09 net cost after partial SELLS ^^ Last partial SELL https://stocktwits.com/G101SPM/message/627987915 BRIEF: uardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data showing the critical role of blood-based testing in increasing cancer screening adherence at the American College of Gastroenterology (ACG) 2025 Annual Meeting in Phoenix, Arizona taking place Friday, October 24 -- Wednesday, October 29, 2025.
1 · Reply
Whiskey1679
Whiskey1679 Oct. 26 at 8:28 PM
Whiskey's Penny Picks out Monday by 6:15 a m PDT!! Movers & Shakers: $SOL.X $CFG $PUMP.X $FCNCA $GH
0 · Reply
Gator5326
Gator5326 Oct. 26 at 7:27 PM
$GH The gift that keeps on giving!
0 · Reply
Gator5326
Gator5326 Oct. 26 at 7:25 PM
$GH Boom! “The findings demonstrated an over 90% adherence rate for Shield, tracking well above average screening adherence for overall CRC testing which ranges from 28-71%”
0 · Reply
Gator5326
Gator5326 Oct. 26 at 7:24 PM
$GH ****Sunday news**** https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZ-2FtX741n0Z6WOyiD4GHhsE2ot5GqmAvyBExw8uY-2BwbjPW-2F4xqt47BrmRH3EMU0y-2FyqAcMcDExPUAs8F76BTBw-2BUBW-2FfT4GTkL15PLbBYTq1Ui75-2FPRJtG53NcIAX3NDWnh8y239HySOItP5q-2Ba5OZSFw3QivLmMiqxV0vHz-2FctCi1Uu0-2BNz0RMt8NTV-2FoyQ-2Bair0ms5ffD90GmEU5hQPyi0-3DHK1i_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMnunjAlxvMqoc2PROnJcq-2F-2BjTdrUKUHALUW-2F6seZll0cuWa0TNbPjXoKuMZ9KqApboP-2BEyePTbK5Fln-2B0lOpg20LCfUKpSrw8VW0uNBNhhC70dwwnnCTJA-2BKyd9Gpzwv1ZFMtJuCTC-2BOe8zmtQwYTLeZVWczt-2FOMrWAXIsyCmBBLrgM2goMIMyGYsIlNjCQZLHiTzeFe4xIRMIqTxYvgQfKiREbuaj-2BbhoRvEixrDRJhgfK7PoszenozQdiC4JilVLngdJaFV0A5eTtZCgF4sk0jC8YLKMOLjNH6dko8K5lT4k99X3UxlRgNF4pa1Uu89Q-3D-3D
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Oct. 26 at 4:15 PM
$GH Clean 3-year+ breakout on volume. Short float % still 6%+, should lend fuel for a quick run to $100+ where i will take profit
0 · Reply
DanaBlack
DanaBlack Oct. 26 at 12:52 AM
$BYND ALL BLACKROCK OWNED. $PLUG $BE $GH GO LONG!
0 · Reply
DanaBlack
DanaBlack Oct. 26 at 12:35 AM
$GH is gonna run like $BE did! FOLLOW BIG MONEY! $BYND $PLUG
0 · Reply
Latest News on GH
Guardant Health, Inc. (GH) Analyst/Investor Day Transcript

Sep 24, 2025, 7:17 PM EDT - 4 weeks ago

Guardant Health, Inc. (GH) Analyst/Investor Day Transcript


Alex M. Azar II Joins Guardant Health Board of Directors

Sep 15, 2025, 4:07 PM EDT - 5 weeks ago

Alex M. Azar II Joins Guardant Health Board of Directors


Guardant Health to Host Investor Day on September 24, 2025

Aug 28, 2025, 4:05 PM EDT - 2 months ago

Guardant Health to Host Investor Day on September 24, 2025


Guardant Health, Inc. (GH) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 11:13 AM EDT - 3 months ago

Guardant Health, Inc. (GH) Q2 2025 Earnings Call Transcript


Guardant Health to Participate in Upcoming Investor Conferences

May 8, 2025, 4:05 PM EDT - 6 months ago

Guardant Health to Participate in Upcoming Investor Conferences


Guardant Health, Inc. (GH) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 10:25 PM EDT - 6 months ago

Guardant Health, Inc. (GH) Q1 2025 Earnings Call Transcript


Gator5326
Gator5326 Oct. 27 at 12:38 PM
$GH https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZ-2FtX741n0Z6WOyiD4GHhsE2ot5GqmAvyBExw8uY-2BwbjPTzHaP7bKqEpZmadhOl9zFfYwOJqXOBKDlZD7Us-2FeyD8y7z46F6g99dFNH4muQpwFgwwtdTph5FXl5yTVXWQt-2FbmKCa8Nz1euwQSRZXVcJfSkRa1KYNzsQHWFJ-2BQsOvbtuYDGmLgm1Pjpzyk8EgvLxw-3D-3DhSVn_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMvl-2BOrlyeCDUu2kwjGbk6bRymO58QHLh7xFAgbOsDXU1yE4V4onqmynjgpQUylrrmnPQluM9zGrh4qFeKmppq0aZ1tObjyWcNVrnGpM4Ucsj8AseoZnYwl43NHabvyGSeu06KYZJhMbMku0be4k8Snx8c-2FUQKczO7CpNahJyE7zQ11BrArQpeGDvn0Jybsr4tpBziHR1MSCuV09pC1FCNQCvrgT3W4CDSx-2FlziTK12SOqZHtEcNGrtgWaPwHaZXBxtXWsxfjGQ4gZ-2BbqxbufTxiQrTAuy0k1MA6PtsNjYmK3 😎😎😎
0 · Reply
Gator5326
Gator5326 Oct. 27 at 11:15 AM
$GH 90% adherence means one thing…..increased revenues! 😎
0 · Reply
G101SPM
G101SPM Oct. 27 at 9:55 AM
$GH $72.15 last bid. Holding long position at $15.09 net cost after partial SELLS ^^ Last partial SELL https://stocktwits.com/G101SPM/message/627987915 BRIEF: uardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data showing the critical role of blood-based testing in increasing cancer screening adherence at the American College of Gastroenterology (ACG) 2025 Annual Meeting in Phoenix, Arizona taking place Friday, October 24 -- Wednesday, October 29, 2025.
1 · Reply
Whiskey1679
Whiskey1679 Oct. 26 at 8:28 PM
Whiskey's Penny Picks out Monday by 6:15 a m PDT!! Movers & Shakers: $SOL.X $CFG $PUMP.X $FCNCA $GH
0 · Reply
Gator5326
Gator5326 Oct. 26 at 7:27 PM
$GH The gift that keeps on giving!
0 · Reply
Gator5326
Gator5326 Oct. 26 at 7:25 PM
$GH Boom! “The findings demonstrated an over 90% adherence rate for Shield, tracking well above average screening adherence for overall CRC testing which ranges from 28-71%”
0 · Reply
Gator5326
Gator5326 Oct. 26 at 7:24 PM
$GH ****Sunday news**** https://u18966101.ct.sendgrid.net/ls/click?upn=u001.4ITdg8fiPHHXRRODKhpNknNKs0V2h8ItR6Q2oQCQKcTyRrxC8ZerlixSyXRNZh4ketL7E2RWkAerRsZCr7TPZ-2FtX741n0Z6WOyiD4GHhsE2ot5GqmAvyBExw8uY-2BwbjPW-2F4xqt47BrmRH3EMU0y-2FyqAcMcDExPUAs8F76BTBw-2BUBW-2FfT4GTkL15PLbBYTq1Ui75-2FPRJtG53NcIAX3NDWnh8y239HySOItP5q-2Ba5OZSFw3QivLmMiqxV0vHz-2FctCi1Uu0-2BNz0RMt8NTV-2FoyQ-2Bair0ms5ffD90GmEU5hQPyi0-3DHK1i_n7gaS9t6bMxECCQWPRdwdqPZyOAjF4RSivuNxLLPR-2FSmysoqQW1ClVyewMaUHyr5PXnLg-2BfGbSor9w1GLElWTiEw3tZro1MLP1IzWdS5qPpbfYGAtnJcrhAqCrHeCZaHRgIG36Opi-2BfPD0wkS0BpMnunjAlxvMqoc2PROnJcq-2F-2BjTdrUKUHALUW-2F6seZll0cuWa0TNbPjXoKuMZ9KqApboP-2BEyePTbK5Fln-2B0lOpg20LCfUKpSrw8VW0uNBNhhC70dwwnnCTJA-2BKyd9Gpzwv1ZFMtJuCTC-2BOe8zmtQwYTLeZVWczt-2FOMrWAXIsyCmBBLrgM2goMIMyGYsIlNjCQZLHiTzeFe4xIRMIqTxYvgQfKiREbuaj-2BbhoRvEixrDRJhgfK7PoszenozQdiC4JilVLngdJaFV0A5eTtZCgF4sk0jC8YLKMOLjNH6dko8K5lT4k99X3UxlRgNF4pa1Uu89Q-3D-3D
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Oct. 26 at 4:15 PM
$GH Clean 3-year+ breakout on volume. Short float % still 6%+, should lend fuel for a quick run to $100+ where i will take profit
0 · Reply
DanaBlack
DanaBlack Oct. 26 at 12:52 AM
$BYND ALL BLACKROCK OWNED. $PLUG $BE $GH GO LONG!
0 · Reply
DanaBlack
DanaBlack Oct. 26 at 12:35 AM
$GH is gonna run like $BE did! FOLLOW BIG MONEY! $BYND $PLUG
0 · Reply
Whales22
Whales22 Oct. 23 at 6:34 AM
How much volume do you think it takes to Gap BBGI up? BBGI has not even 700k shares float and recent news. Hoping for a 100% run on BBGI $GH $TOI $BYSI $GT Watchlist,
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 3:08 PM
Piper Sandler updates rating for Guardant Health ( $GH ) to Overweight, target set at 60 → 90.
0 · Reply
TalkMarkets
TalkMarkets Oct. 22 at 9:42 AM
Markets Are Choppy, But This One Zone Could Tell Us What’s Next For The S&P 500 $SPX $GH $BABA $PVLA https://talkmarkets.com/content/stocks--equities/markets-are-choppy-but-this-one-zone-could-tell-us-whats-next-for-the-sp-500?post=529717&userid=166882
0 · Reply
StockHunter75
StockHunter75 Oct. 21 at 5:41 PM
$GH Added some
0 · Reply
LadyBABA
LadyBABA Oct. 21 at 3:19 PM
$GH 10 year cup going to form
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Oct. 21 at 11:40 AM
$GH May test 80
0 · Reply
Gator5326
Gator5326 Oct. 20 at 9:45 PM
$GH Gator5326 Jul 16, 2025 4:51 PM @RNASequencing If you are short term it is. GH is a long term hold. $70-$80 end of year imho Bullish
0 · Reply
ProtectThisHouse
ProtectThisHouse Oct. 20 at 8:20 PM
$GH That was fast. Hope you held.
1 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Oct. 20 at 7:56 PM
$GH $NTRA $EXAS long all these molecular diagnostics names
2 · Reply
WantedToRetireEarly
WantedToRetireEarly Oct. 20 at 3:35 PM
$GRAL $GH Good time for Grail to raise capital and market likes it The private placement included the participation by new and existing institutional investors, including Deep Track Capital, Farallon Capital Management, Hims & Hers, Braidwell LP, three life sciences investment firms, and a tech and life sciences focused family office investment firm. GRAIL currently expects to use the net proceeds from the private placement to fund its commercial activities and reimbursement efforts, as well as for working capital and other general corporate purposes. GRAIL believes its cash, cash equivalents and investments, including the expected net proceeds from the private placement, will provide sufficient funding of planned operations into 2030, not including the previously announced agreement by Samsung C&T and Samsung Electronics to invest $110 million in the Company, subject to closing conditions.
1 · Reply
The1Albatross
The1Albatross Oct. 16 at 9:07 PM
$GH ;) Lifer
0 · Reply
WantedToRetireEarly
WantedToRetireEarly Oct. 16 at 7:40 PM
1 · Reply